{"_id":"dihKxfb7pwjphiXka","bibbaseid":"sonne-hansen-knop-bileacidsequestrantsintype2diabetespotentialeffectsonglp1secretion-2014","author_short":["Sonne, D. P","Hansen, M.","Knop, F. K"],"bibdata":{"bibtype":"article","type":"article","title":"Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.","volume":"171","issn":"1479-683X","url":"http://www.ncbi.nlm.nih.gov/pubmed/24760535","doi":"10.1530/EJE-14-0154","number":"2","urldate":"2014-12-18","journal":"European Journal of Endocrinology","author":[{"propositions":[],"lastnames":["Sonne"],"firstnames":["David","P"],"suffixes":[]},{"propositions":[],"lastnames":["Hansen"],"firstnames":["Morten"],"suffixes":[]},{"propositions":[],"lastnames":["Knop"],"firstnames":["Filip","K"],"suffixes":[]}],"month":"August","year":"2014","pmid":"24760535","keywords":"Allylamine, Allylamine: analogs & derivatives, Allylamine: pharmacology, Animals, Bile Acids and Salts, Bile Acids and Salts: metabolism, Blood Glucose, Blood Glucose: drug effects, Blood Glucose: metabolism, Cytoplasmic and Nuclear, Cytoplasmic and Nuclear: physiology, Diabetes Mellitus, Energy Metabolism, Energy Metabolism: drug effects, Fibroblast Growth Factors, Fibroblast Growth Factors: physiology, G-Protein-Coupled, G-Protein-Coupled: metabolism, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1: physiology, Glucagon-Like Peptide 1: secretion, Humans, Lipid Metabolism, Lipid Metabolism: drug effects, Receptors, Type 2, Type 2: drug therapy, Type 2: metabolism, Type 2: physiopathology","pages":"R47–65","author_short":["Sonne, D. P","Hansen, M.","Knop, F. K"],"key":"Sonne2014a","id":"Sonne2014a","bibbaseid":"sonne-hansen-knop-bileacidsequestrantsintype2diabetespotentialeffectsonglp1secretion-2014","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/24760535"},"keyword":["Allylamine","Allylamine: analogs & derivatives","Allylamine: pharmacology","Animals","Bile Acids and Salts","Bile Acids and Salts: metabolism","Blood Glucose","Blood Glucose: drug effects","Blood Glucose: metabolism","Cytoplasmic and Nuclear","Cytoplasmic and Nuclear: physiology","Diabetes Mellitus","Energy Metabolism","Energy Metabolism: drug effects","Fibroblast Growth Factors","Fibroblast Growth Factors: physiology","G-Protein-Coupled","G-Protein-Coupled: metabolism","Glucagon-Like Peptide 1","Glucagon-Like Peptide 1: physiology","Glucagon-Like Peptide 1: secretion","Humans","Lipid Metabolism","Lipid Metabolism: drug effects","Receptors","Type 2","Type 2: drug therapy","Type 2: metabolism","Type 2: physiopathology"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/arbones","dataSources":["HYaQtBq73JSgvuWz5"],"keywords":["allylamine","allylamine: analogs & derivatives","allylamine: pharmacology","animals","bile acids and salts","bile acids and salts: metabolism","blood glucose","blood glucose: drug effects","blood glucose: metabolism","cytoplasmic and nuclear","cytoplasmic and nuclear: physiology","diabetes mellitus","energy metabolism","energy metabolism: drug effects","fibroblast growth factors","fibroblast growth factors: physiology","g-protein-coupled","g-protein-coupled: metabolism","glucagon-like peptide 1","glucagon-like peptide 1: physiology","glucagon-like peptide 1: secretion","humans","lipid metabolism","lipid metabolism: drug effects","receptors","type 2","type 2: drug therapy","type 2: metabolism","type 2: physiopathology"],"search_terms":["bile","acid","sequestrants","type","diabetes","potential","effects","glp1","secretion","sonne","hansen","knop"],"title":"Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.","year":2014}